. Author manuscript; available in PMC: 2018 Nov 1.

Published in final edited form as: Anesth Analg. 2017 Nov;125(5):1682–1703. doi: 10.1213/ANE.0000000000002426

Table 5.

Post-herpetic Neuralgia – Effective Medications based on Included Studies

Post-herpetic Neuralgia – Effective Medications

FDA On-Label	Off-Label
*Topical (non-local anesthetic)*
Capsaicin 0.025%; 0.075%; 0.025%–10%–25%; 0.035%; 0.1%; 8%; 0.25%; Capsaicin Patch (8%)	None

*Amine Reuptake Inhibitors (ARI)*
None	Amitriptyline, Desipramine, NortriptylineFluoxetine

*Membrane Stabilizers*
Gabapentin, Gabapentin GR, Gabapentin Enacarbil, Pregabalin	Levetiracetam

*ARI/Opioid*
None	Tramadol

*Local Anesthetics*
Lidocaine Patch (5%)	None

*NMDA Antagonists*
None	None

*Miscellaneous*
None	Botulinum Toxin Type A

FDA: Food and Drug Administration; ARI: amine reuptake inhibitor; NMDA: N-methyl-D-aspartate